Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2024

Open Access 01-12-2024 | Correction

Correction: Clinical inertia in newly diagnosed type 2 diabetes mellitus among patients attendingselected healthcare institutions in Colombia

Authors: Nelson Alvis-Guzman, Martín Romero, Fernando Salcedo-Mejia, Maria Carrasquilla-Sotomayor, Lina Gomez, Mónica María Rojas, Juan Camilo Urrego, Claudia Catalina Beltrán, Jaime Enrique Ruíz, Adriana Velásquez, Juan Carlos Orengo, Adolfo Pinzón

Published in: Diabetology & Metabolic Syndrome | Issue 1/2024

Login to get access

Excerpt

Correction: Diabetology & Metabolic Syndrome (2024) 16:42
Metadata
Title
Correction: Clinical inertia in newly diagnosed type 2 diabetes mellitus among patients attendingselected healthcare institutions in Colombia
Authors
Nelson Alvis-Guzman
Martín Romero
Fernando Salcedo-Mejia
Maria Carrasquilla-Sotomayor
Lina Gomez
Mónica María Rojas
Juan Camilo Urrego
Claudia Catalina Beltrán
Jaime Enrique Ruíz
Adriana Velásquez
Juan Carlos Orengo
Adolfo Pinzón
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2024
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-024-01300-4

Other articles of this Issue 1/2024

Diabetology & Metabolic Syndrome 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.